Multimodal management for gastroesophageal reflux disease (GERD) includes medications, endoscopic therapies, and anti-reflux operations. Anti-reflux surgery for refractory GERD has satisfactory outcomes in 85–90% of patients. However, redo anti-reflux surgeries offer less satisfactory morbidity, mortality, and symptomatic outcomes than after primary surgery. Over the past years, endotherapy has emerged as a promising management strategy for uncomplicated GERD.
Furthermore, meticulous patient selection and awareness of the advantages and disadvantages of management options, including revision anti-reflux surgery and endotherapy, are essential to optimize outcomes. Join the expert surgeons to discuss “ Anti-reflux Operations: Is Surgery Giving Way to Endotherapy? | Revisions for Failed Anti-reflux Operations ” in an exclusive session, organized in association with IAGES , on 27 th April…
